from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0035/fadD34

LFCtreatmentdescriptionclass of inhibitor

0.040

Amikacinug/mL Amikacintranslation

-0.057

Cap5-10ug/mL Capreomycintranslation

-0.480

Rox10-50 ug/mL Roxithromycintranslation

0.044

SM2-5 ug/mL Streptomycintranslation

-0.967

Tet5-10 ug/mL Tetracyclinetranslation

0.800

Rif0.2-5ug/mL Rifampicintranscription

0.547

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.367

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.057

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.077

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.986

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.397

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.778

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.131

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.000

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.455

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.069

Nigericin50 uM Nigericinrespiration

-0.332

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.002

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.606

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.525

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.164

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.354

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.374

Amp0.2mg/mL AmpicillincellWall

0.248

Cephalexin20-100 ug/mL CephalexincellWall

-0.480

Cerulenin0.32-5 ug/mL CerulenincellWall

0.971

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.152

EMB10-20 ug/mL EthambutolcellWall

0.660

Eta12-40 ug/mL EthionamidecellWall

0.169

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.226

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.545

BZA0.12 mg/mL BenzamidearomaticAmides

0.915

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.416

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.201

H2O24 mM hydrogen peroxideDNAdamaging

0.343

Levo10 ug/mL LevofloxacinDNAdamaging

0.119

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.272

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.095

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.156

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.372

Antimycin12.5-50 ug/mL Antimycin A?

0.307

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.400

PA_110-50 ug/mL Antitubercular compound PA-1?

0.237

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.500

PA8240.2-2 ug/mL PA-824?

-2.715

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.898

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.054

Verapamil50 uM Verapamil?

-0.244

mercaptoethanol2 mM 2-Mercaptoethanol?

0.398

methoxatin10-20 ug/mL Methoxatin?